Chubu University

Chubu University is a private educational institution registered to receive federal grant awards from the U.S. government. As a foreign-owned, tax-exempt corporate entity, Chubu University is classified as a private university or college and operates as a non-profit organization. The university has maintained an active registration in SAM.gov since July 2016, with its current registration set to expire in November 2024. Through its participation in federal grant programs, Chubu University contributes specialized research services to U.S.-funded scientific initiatives, particularly in the field of genetic engineering and molecular biology.

Based on the available grant sub-award information, Chubu University has been involved in advanced genetic research, specifically focusing on CRISPR-mediated gene knock-out studies. These studies form a crucial component of a larger research project, as outlined in Aim 3 of the grant proposal. The university's involvement in this research is facilitated through a partnership with the University of New Mexico, which serves as the prime grantee for the project. Dr. Reiko Kuroda from Chubu University has been designated as the responsible party for conducting these gene knock-out studies. The repetition of this sub-award across multiple grant IDs suggests an ongoing collaboration or a multi-phase research project, likely funded by the National Institute of Allergy and Infectious Diseases (NIAID), as indicated by the "AI" in the grant numbers. This partnership demonstrates Chubu University's capability to contribute specialized expertise to international collaborative research efforts in the field of genetic engineering and molecular biology.